Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof

A technology of LID-PEG-PLGA and nano-microspheres, which is applied in the field of slow-release microspheres and its preparation, can solve problems such as increasing bioavailability, prolonging the action time of LID, and reducing the number of administrations, so as to increase bioavailability, The effect of reducing the frequency of administration and prolonging the action time

Inactive Publication Date: 2012-02-01
ARMY MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, since its drug loading is only (12.48 ± 0.26)%, and its encapsulation efficiency is only (54.30 ± 0.89)%, so when prolonging the action time of LID one-time administration, reducing the number of administrations and increasing biological In terms of utilization, there are still some deficiencies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof
  • LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof
  • LID-PEG-PLGA controlled-release nano microsphere and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] A LID-PEG-PLGA sustained-release nanometer microsphere is a sustained-release nanometer microsphere containing lidocaine and a degradable carrier, and the degradable carrier contains a lactic acid-glycolic acid copolymer. In the present invention, there is also polyethylene glycol in the degradable carrier, and the mass percentage of the polyethylene glycol and lactic acid-glycolic acid copolymer is 1:20 to 1:10; The mass percentage in is 30-35%; wherein, the polyethylene glycol is PEG-2000.

[0025] Furthermore, as a preferred solution, in the lactic acid-glycolic acid copolymer, the mass ratio of the two monomers is 75:25-50:50. With this preferred proportion of the polymer as the matrix, a more stable and lasting release effect will be obtained.

[0026] A method for preparing LID-PEG-PLGA slow-release nano-microspheres, the LID-PEG-PLGA slow-release nano-microspheres described in the method are the above-mentioned slow-release nano-microspheres in this specific emb...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses an LID-PEG-PLGA controlled-release nano microsphere and a preparation method thereof. The microsphere is the controlled-release microsphere which contains medicinal lidocaine and a degradable carrier. The degradable carrier contains polylactic-glycolic acid and PEG-2000. The mass percentage of the lidocaine in the controlled-release microsphere is 30 to 35 percent. The preparation method comprises the following steps of: preparing the carrier into matrix solution; dispersing the lidocaine into the matrix solution and preparing the lidocaine into an oil phase; mixing the oil phase and the aqueous solution of polyvinyl alcohol, and performing ultrasonic emulsification on the mixture under a water bath condition to obtain W / O-type protogala; mixing the W / O-type protogala and the aqueous solution of polyvinyl alcohol again, and further emulsifying the mixture into W / O / W-type complex emulsion; volatilizing the emulsion by reducing pressure at the normal temperature to obtain cured lidocaine-carried nano microsphere; and scattering, blending, packaging, freezing, sterilizing and the like. The medicament loading rate of the controlled-release nano microsphere can be up to 15 to 22 percent; the entrapment rate can be up to 68 to 78 percent; and the half-life period can be prolonged to 3 to 4 days. Therefore, the microsphere has relatively good effect of burst in the first day after the microsphere is taken and good effect of slow release in later days.

Description

technical field [0001] The invention relates to a lidocaine-loaded slow-release microsphere and a preparation method thereof. Background technique [0002] Lidocaine (Lidocaine, LID), also known as xylocaine, chemical name: N-(2,6-xylyl)-2-(diethylamino)acetamide. Lidocaine has an obvious inhibitory effect on the central nervous system and is a commonly used local anesthetic in clinical practice. After 2006, people discovered its potential new clinical use, which can be used as an early treatment drug for severe trauma. However, because lidocaine can dilate peripheral blood vessels, drug absorption through blood vessels will be accelerated, which will shorten the period of action; at the same time, because lidocaine has a short biological half-life (only 1.5 to 2 hours), it is clinically Just need small dose frequent administration to maintain its drug effect when using, and this just brings bigger misery and inconvenience to the patient. Therefore, it is of great signific...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/14A61K9/51A61K9/52A61K47/34A61K31/167A61P23/00
Inventor 赵先英粟永萍刘毅敏肖湘高继宁刘海红李明春
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com